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Abstract:  Transient  forebrain  or  global  ischemia  induces  neuronal  death  in  vulnerable 
CA1  pyramidal  cells  with  many  features.  A  brief  period  of  ischemia,  i.e.,  ischemic 
preconditioning, or a modified reperfusion such as ischemic postconditioning, can afford 
robust protection of CA1 neurons against ischemic challenge. Therefore, we investigated 
the effect of ischemic preconditioning and postconditioning on neural cell apoptosis in rats. 
The result showed that both ischemic preconditioning and postconditioning may attenuate the 
neural cell death and DNA fragment in the hippocampal CA1 region. Further western blot 
study  suggested  that  ischemic  preconditioning  and  postconditioning  down-regulates  the 
protein  of  cleaved  caspase-3,  caspase-6,  caspase-9  and  Bax,  but  up-regulates  the  protein  
Bcl-2.  These  findings  suggest  that  ischemic  preconditioning  and  postconditioning  have  a 
neuroprotective role on global brain ischemia in rats through the same effect on inhibition  
of apoptosis. 
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1. Introduction 
Brain ischemia is becoming a leading cause of morbidity and mortality world-wide [1]. Its major 
pathophysiological manifestation is acute brain ischemia-reperfusion injury [2].  
A  variety  of  clinical  trials  of  pharmacological  neuroprotective  strategies  in  stroke  have  been 
disappointing [3–5]. Therefore, innovative treatment strategies  for protecting the brain  against the 
detrimental effects of this form of injury are required in order to improve clinical outcomes in patients 
with brain ischemic injury. Researchers are now interested in the brain’s endogenous strategies for 
neuroprotection  [6,7].  Harnessing  the  endogenous  protection  elicited  by  the  brain’s  ability  to 
“condition” itself has recently emerged as a powerful new strategy for limiting brain injury [8,9]. The 
concept of ischemic preconditioning is defined as a brief noninjurious episode of ischemia which can 
protect  the  brain  from  a  subsequent  longer  ischemic  insult  [10,11].  This  strategy  to  attenuate  the 
pathophysiological consequences of ischemic injury would be focused on pretreatment situations, such 
as  protection  before  bypass  surgery.  But  a  non-pharmacological  neuroprotective  strategy  for 
therapeutic application after ischemia onset remains elusive. Recently, many researchers demonstrated 
that  a  modified  reperfusion  in  the  same  artery  occluded  to  produce  a  prolonged  episode  of  focal 
cerebral  ischemia  may  confer  postischemic  neuroprotection  [12].  This  phenomenon  was  termed 
ischemic postconditioning. 
Some  studies  have  suggested  that  pre-  and  postconditioning  are  similar  phenomena  with  the 
effectors being a similar group of downstream signaling cascades [13]. Other studies suggest that the 
mechanisms  regulating  postconditioning  may  be  entirely  different  from  preconditioning  [14].  The 
reason  is  that  the  rapidity  of  onset  of  postconditioning-induced  neuroprotection  contrasts  with  a 
significant temporal delay for protein synthesis-dependent, preconditioning-induced neuroprotection. 
Therefore,  we  investigated  the  neuroprotective  effect  of  ischemic  preconditioning  and 
postconditioning  on  global  brain  ischemia  in  rats.  We  further  identified  the  effect  of  ischemic 
preconditioning  and  postconditioning  on  neural  cell  apoptosis  and  apoptosis-related  proteins.  Our 
results  showed  that  ischemic  preconditioning  and  postconditioning  have  a  relatively  equal 
neuroprotective  role  on  global  brain  ischemia  in  rats  through  the  same  effect  on  inhibition  of  
neuronal apoptosis. 
2. Results and Discussion 
2.1. Neuronal Injury Following Global Cerebral Ischemia Is Reduced by Ischemic Preconditioning 
and Postconditioning 
We examined whether preconditioning and postconditioning were associated with an increase in 
neuronal cell survival in the hippocampal CA1 region after ischemia. For rats in the sham group, the 
CA1 region contained 3 to 4 layers of pyramidal cells in a regular arrangement under cresyl violet Int. J. Mol. Sci. 2012, 13  6091 
 
 
staining (Figure 1a). At high magnification, the pyramidal cells were large, round, transparent and had 
intact nuclei (Figure 1b). In contrast, three days after lethal ischemia, most CA1 pyramidal cells were 
shrunken with pyknotic nuclei (Figure 1c,d). In the case of an ischemic insult, neuronal density was 
significantly increased by preconditioning and postconditioning compared to the ischemic insult alone 
(p < 0.01, Figure 1c–h). Hippocampal CA1 cell counts revealed that the percentages of viable neurons 
in the Isch, IPre, and IPost groups were 20.7 ±  2.1%, 58.6 ±  3.8% and 63.5 ±  5.6%, respectively 
(Figure 1, p < 0.01). 
Figure 1. Effects of ischemic preconditioning and postconditioning on ischemia-induced 
neuronal cell loss in hippocampal CA1 regions. Animals were subjected to sham operation 
(Sham, a, b), global ischemia (Isch, c, d), preconditioning (IPre, e, f) and postconditioning 
(IPost, g, h). Three days later, brains were fixed with 4% paraformaldehyde followed by 
preparation of coronal  sections  from  frozen brains  and subsequent  staining  with  cresyl 
violet to determine cell survival in neuronal layers of the hippocampi (n = 5). The boxed 
areas of CA1 subfield are shown at higher magnification, and the number of viable neurons 
in these areas was counted. Images of hippocampi at lower magnification (× 40) are a, c, e 
and  g,  and  images  at  higher  (× 400)  are  b,  d,  f,  and  h.  Scale  bar  =  30  µm.  Data  are  
mean  ±   S.D.  *  p  <  0.01  by  nonparametric  ANOVA  followed  by  Dunn’s  analysis 
comparing with ischemic rats. 
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TUNEL staining was applied to examine DNA fragmentation in neurons undergoing apoptosis after 
ischemia. TUNEL labeling was undetectable in the CA1 region in sham groups (Figure 2a). But global 
ischemia induced a marked increase in the incidence of TUNEL-positive CA1 neurons (Figure 2b). 
Preconditioning  and  postconditioning  significantly  blocked  ischemia-induced  DNA  fragmentation 
indicated by TUNEL (p < 0.01, Figure 2c,d). The number of apoptotic cells in the CA1 region in the Isch, 
IPre, and IPost groups were 76.8 ±  5.1%, 38.9 ±  2.1% and 40.9 ±  3.2%, respectively (Figure 2, p < 0.01). 
Figure 2. Effects of ischemic preconditioning and postconditioning on ischemia-induced 
neuronal  apoptosis  in  hippocampal  CA1  regions.  Animals  were  subjected  to  sham 
operation  (Sham,  a),  global  ischemia  (Isch,  b),  preconditioning  (IPre,  c)  and 
postconditioning (IPost,  d). Three days  later,  animals  were killed  and  coronal  sections  
(18  mm)  of  fresh-frozen  rat  brain  were  cut  by  cryotome.  Sections  were  fixed  in  4% 
paraformaldehyde  for  60  min  at  room  temperature  and  processed  for  TUNEL  nuclear 
staining (n = 5). Scale bar = 30 µm. The arrows point to the apoptotic cells. Data are  
mean  ±   S.D.  *  p  <  0.01  by  nonparametric  ANOVA  followed  by  Dunn’s  analysis 
comparing with ischemic rats. 
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2.2. Downregulation of Hippocampal Cleaved Caspase-3, Cleaved Caspase-6, Cleaved Caspase-9  
and Bax 
Western  blot  was  used  to  assess  the  effect  of  global  ischemia,  ischemic  preconditioning  and 
postconditioning on apoptosis-related protein expression. Western  blot analysis revealed that three 
days after reperfusion, the expression levels of cleaved caspase-3 in the sham, Isch, IPre, and IPost 
groups were 0.11 ±  0.04, 0.92 ±  0.05, 0.65 ±  0.05 and 0.35 ±  0.04, respectively (Figure 3a,b). While 
the expression levels of cleaved caspase-6 in the sham, Isch, IPre, and IPost groups were 0.08 ±  0.01, 
1.02 ±  0.09, 0.45 ±  0.05 and 0.55 ±  0.04, respectively (Figure 3a,c). The expression levels of cleaved 
caspase-9 in the sham, Isch, IPre, and IPost groups were 0.06 ±  0.01, 0.65 ±  0.09, 0.32 ±  0.06 and  
0.35 ±  0.05, respectively (Figure 3a,d). Also, our data found that the expression levels of Bax in the 
sham,  Isch,  IPre, and  IPost groups  were 0.32  ±  0.01, 0.92 ±  0.05, 0.55 ±  0.08 and 0.58 ±   0.05, 
respectively  (Figure  4a,b,  p  <  0.01).  The  results  showed  that  both  ischemic  preconditioning  and 
postconditioning  downregulate  the  expression  of  cleaved  caspase-3,  caspase-6,  caspase-9  and  Bax 
(Figures 3,4, p < 0.01). Int. J. Mol. Sci. 2012, 13  6094 
 
 
Figure 3. Western blotting analysis of cleaved caspase expressions in hippocampal CA1 
regions.  Animals  were  subjected  to  sham  operation  (Sham),  global  ischemia  (Isch), 
preconditioning (IPre) and postconditioning (IPost). Three days later, extracts from the 
hippocampi  of  the  rats  and  sham  controls  were  subjected  to  western  blotting  with  
anti-cleaved  caspase-3  (B),  anti-cleaved  caspase-6  (C)  and  anti-cleaved  caspase-9  (D) 
protein. Data are mean ±  S.D. (n = 5). * p < 0.01 by nonparametric ANOVA, followed by 
Dunn’s analysis comparing with ischemic rats. 
 
Figure 4. Western blotting analysis of Bax and Bcl-2 expressions in hippocampal CA1 
regions.  Animals  were  subjected  to  sham  operation  (Sham),  global  ischemia  (Isch), 
preconditioning (IPre) and postconditioning (IPost). Three days later, extracts from the 
hippocampi of the rats and sham controls were subjected to western blotting with anti-Bax (B) 
and anti-Bcl-2 (C) protein. Data are mean ±  S.D. (n = 5). * p < 0.01 by nonparametric 
ANOVA, followed by Dunn’s analysis comparing with ischemic rats. 
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2.3. Upregulation of Hippocampal Bcl-2 
We detected the expression of Bcl-2 in the CA1. Western blot analysis showed that three days after 
reperfusion, the expression levels of Bcl-2 in the sham, Isch, IPre, and IPost groups were 0.28 ±  0.01, 
0.12 ±  0.09, 0.47 ±  0.07 and 0.56 ±  0.04, respectively (Figure 4a,c, p < 0.01). The results indicated that 
ischemic  preconditioning  as  well  as  ischemic  postconditioning  could  upregulate  the  expression  of  
Bcl-2 in the CA1 after ischemic insult in rats (Figure 4, p < 0.01). 
2.4. Discussion 
Our studies showed that lethal ischemic insult for 10 min caused abundant neuronal cell death and 
apoptosis  in  the  hippocampal  CA1  region.  However,  when  the  animals  were  pretreated  with 
preconditioning for 3 min, two days before the lethal ischemic insult, the above neuronal injury was 
significantly attenuated. At the same time, after the modified reperfusion, in which rats were subjected 
to six cycles of 10 s reperfusion and 10 s ischemia, the ischemic injury was also markedly reduced. We 
further  found  that  both  ischemic  preconditioning  and  postconditioning  could  down-regulate  the 
expression of cleaved caspase-3, cleaved caspase-6, cleaved caspase-9 and Bax, but up-regulate the 
protein Bcl-2 in the hippocampus. This suggests that preconditioning and postconditioning have the 
same effect on anti-apoptosis against the ischemia-reperfusion injury. 
Brain ischemic injury, resulting either from global or focal decreases in perfusion, is among the 
most  common  and  important  causes  of  disability  and  death  worldwide  [1].  These  patients  may 
experience a variety of difficulties such as dyskinesia, sensory disturbance, memory impairment, and 
many emotional and social problems following the ischemic injury [15]. However, until now, most of 
the  symptoms  could  not  be  improved  by  psychological  or  psychiatric  treatment  [16,17]. 
Neuroprotection or brain repair in patients after acute brain ischemic injury is a major unmet medical 
need.  Pharmacological  treatments  are  either  ineffective  or  confounded  by  adverse  effects  [18]. 
Consequently, endogenous mechanisms by which the brain protects itself against noxious stimuli and 
recovers from damage are being studied [19]. 
Ischemic  conditioning  offers  a  way  to  induce  endogenous  neuroprotection  [20].  Ischemic 
conditioning has been defined as the practice of applying brief episodes of nonlethal ischemia and 
reperfusion to confer protection against a sustained episode of lethal ischemia and reperfusion injury. 
Now, it is regarded as one potential therapeutic strategy. Importantly, the protective stimulus can be 
applied before (ischemic preconditioning) or after (ischemic postconditioning) onset of the sustained 
episode  of  lethal  ischemia.  But  until  now,  the  basic  biology  of  both  preconditioning  and 
postconditioning has been unclear [21]. The major unknowns for both conditioning responses include 
the  process  or  substances  that  trigger  the  cascade  of  events  which  will  lead  to  attenuation  of 
reperfusion  injury.  In  our  previous  studies  [11,22],  we  have  investigated  the  effect  of  ischemic 
preconditioning  or  ischemic  postconditioning.  Our  studies  have  demonstrated  that  both  ischemic 
preconditioning and postconditioning may protect neuron injury after brain ischemic brain. We ask if 
they  have the same neuroprotective mechanism  which  may  become the  same brain protective target. 
Therefore, in our study we investigated if both pre- and postconditioning can trigger anti-apoptotic function. Int. J. Mol. Sci. 2012, 13  6096 
 
 
The term “programmed cell death” (apoptosis) is characterized by a series of well-defined and 
distinct  morphological  and  biochemical  changes  [23].  Apoptosis  is  triggered  following  cerebral 
ischemia  by  a  variety  of  death  signals,  especially  caspase  activation  [24,25].  Caspases,  or  
cysteine-dependent, aspartate-directed proteases, are a family of cysteine proteases that play essential 
roles in apoptosis. Scientists have termed caspases as “executioner” proteins. There are two types of 
apoptotic caspases: initiator (apical) caspases and effector (executioner) caspases. Caspase-9 belongs 
to the initiator caspases, but the caspase-3 and caspase-6 are related to effector caspases. So, in this 
study,  we  detected  the  protein  level  of  caspase-3,  -6  and  -9.  Our  results  showed  that  the 
postconditioning can down-regulate the protein more than the pre-conditioning. Although there are no 
significant differences on the caspase-6 and caspase-9 level, the level of caspase-6 and caspase-9 in  
the  pre-conditioning  group  is  higher  than  postconditioning.  This  suggests  a  balance  among  the  
caspase family. 
The  Bcl-2  family  proteins  are  located  at  outer  mitochondria  membranes,  and  it  controls  the 
activation of downstream caspases, thus representing a critical proximal intracellular checkpoint in the 
mitochondria-mediated apoptosis pathway [26,27]. Therefore, western blotting was used to detect the 
protein of caspases and Bcl-2. The results of this study showed that both ischemic preconditioning and 
postconditioning downregulate the expression of hippocampal cleaved caspase-3, caspase-6, caspase-9 
and Bax, but upregulate hippocampal Bcl-2 expression. We found that both ischemic preconditioning 
and postconditioning have the anti-apoptotic function through the same mechanism. 
Until now, there are a number of mechanisms [28–30] which may be related to the conditioning 
effect  on  ischemic  injury,  especially  in  coronary  heart  disease.  A  variety  of  key  molecules  and 
signaling pathways has been found, including GABA receptor, iNOS, adenosine, heat shock protein. 
Also, many novel conditioning methods have been found, such as remote ischemic conditioning [28]. 
It is certain that ischemic tolerance can protect neurons, and at the same time, it also can maintain 
brain  function.  But  there  has  been  little  study  about  the  relationship  between  such  kinds  of 
conditioning, or cross-tolerance. Our further study will focus on the common mechanisms about all 
kinds of conditioning methods which may allow us to exploit the protective effect pharmacologically. 
3. Experimental Section  
3.1. Animals 
Age-matched adult male Sprague-Dawley rats weighing 200–220 g (Nanjing Medical University 
Animal  Laboratories)  were  maintained  in  a  temperature-  and  light-controlled  environment  with  a 
14/10-h light/dark cycle. All subjects were treated in accordance with the principles and procedures of 
the Animal Care and Experimental Committee of the Nanjing Medical University. 
3.2. Establishment of the 4-Vessel Occlusion Model 
Global ischemia was induced using the 4-vessel occlusion method, as described previously [31]. 
Briefly, rats were anesthetized by intraperitoneal administration of 20% chloral hydrate (350 mg/kg) 
on day 1. Both vertebral arteries were electrocauterized, and the bilateral common carotid arteries were 
separated.  On  day  2,  the  bilateral  common  carotid  arteries  of  conscious  rats  were  occluded  with Int. J. Mol. Sci. 2012, 13  6097 
 
 
aneurysm  clips  for  10  min.  During  surgery,  body  temperature  was  monitored  and  maintained  at  
37.5 ±  0.5 ° C with a rectal thermistor and a heat lamp. Rats that had lost the righting reflex, had dilated 
pupils and were unresponsive to light were used in experiments. 
3.3. Ischemic Preconditioning and Postconditioning 
Rats were randomly assigned to four groups (Figure 5). For the ischemic preconditioning group 
(IPre), preconditioning consisted of a three-minute occlusion that took place 48 h prior to the global 
ischemic event.  For the ischemic postconditioning  group (IPost),  global  ischemia was  induced  by 
occluding the common arteries with aneurysm clips, and reperfusion was performed by removing the 
clips.  Immediately  after  reperfusion,  rats  in  the  IP  group  were  subjected  to  six  cycles  of  10  s 
reperfusion and 10 s ischemia. In the sham group (Sham), rats were subjected to the same anesthesia 
and surgical procedures, except that the carotid arteries were not occluded. The protocol is shown  
in Figure 5. 
Figure 5. Experimental protocol used to evaluate the effect of ischemic preconditioning 
and  postconditioning  after  ischemia-reperfusion.  Sham:  sham-operated  rats;  Isch:  rats 
subjected  to  10  min  of  4-vessel  occlusion  (VO)  followed  by  reperfusion;  IPre:  rats 
subjected to a three-minute occlusion that took place 48 h prior to the global ischemic 
event; IPost: rats subjected to 10 min of 4-vessel occlusion followed by postconditioning. 
Postconditioning reperfusion was performed for 10 s, then the bilateral common carotid 
arteries were re-occluded for 10 s and this procedure was repeated 6 times. 
 
3.4. Histological Analysis 
Neuronal  cell  loss  was  assessed  by  histological  examination  of  the  dorsal  hippocampus  
(CA1 region) of brain sections stained with cresyl violet. Animals were sacrificed 72 h after the sham, 
Isch,  IPre  and  IPost  surgeries.  Animals  were  deeply  anesthetized  with  halothane  and  fixed  by 
transcardiac perfusion with ice-cold 4% paraformaldehyde in PBS (0.1 M, pH 7.4). Brains were removed 
and immersed in fixative. Coronal sections (15 µm ) were cut at the level of the dorsal hippocampus 
with a cryotome and stained with cresyl violet. The number of live pyramidal neurons per 250-mm 
length of the medial CA1 region was counted under a light microscope at × 40 magnification. Four 
sections were counted from each rat, with each experimental group consisting of five rats. Int. J. Mol. Sci. 2012, 13  6098 
 
 
3.5. In Situ Labeling of DNA Fragmentation by TUNEL 
To  detect  DNA  fragmentation  in  degenerating  neurons,  animals  were  sacrificed  72  h  after 
reperfusion, and coronal  sections  (18 mm) of freshly-frozen rat  brain  were cut  using a cryotome. 
Sections  were  fixed  in  4%  paraformaldehyde  for  60  min  at  room  temperature  and  processed  for 
TUNEL nuclear staining using an in situ cell death detection kit (Roche Molecular Biochemicals and 
Molecular Probes; manufacturer’s instructions were followed). Images were viewed under a Nikon 
ECLIPSE  TE300  fluorescence  microscope  and  acquired  with  a  SPOT  RT  CCD-cooled  camera 
equipped  with  diagnostic  software  version  3.0.  Imaging  settings  were  kept  constant  across 
experimental and control groups. TUNEL-positive cells were identified directly by the fluorescence 
signal  of incorporated fluorescein-dUTP.  Cells  in  32 fields  sampled from  the CA1 region  of  five 
animals were scored. 
3.6. Western Blotting 
Tissue  samples  were  lysed  in  RIPA  lysis  buffer  on  ice  for  30  min  and  centrifuged  at  
16,000 revolutions per minute for 30 min at 4 °C . Protein concentration was determined using the 
bicinchoninic acid method. Loading buffer was added to each sample (60 μg) and samples were boiled 
for 5 min. Samples were run on sodium dodecyl sulfate polyacrylamide gels and then transferred to 
polyvinylidene  fluoride  membranes  (Immobilon,  Millipore,  Billerica,  MA,  USA).  The  membranes 
were blocked with 5% milk in Tris-buffered saline with Tween (TBST) for 1 h and incubated with the 
following primary antibodies at 4 °C  overnight: rabbit anti-cleaved caspase-3, anti-cleaved caspase-6, 
anti-cleaved caspase-9, anti-Bax and anti-Bcl-2 (1:2000; Abcam, Cambridge, MA, USA) and mouse 
anti-β-actin  (1:1000;  Sigma-Aldrich,  St.  Louis,  MO,  USA).  The  membranes  were  washed  and 
incubated  with  the  following  secondary  antibodies  for  1  h  at  room  temperature  in  the  dark:  goat  
anti-rabbit IRDye 800 CW (1:4000; Kirkegaard and Perry Laboratories [KPL], Gaithersburg, MD, 
USA) and goat anti-mouse IRDye 800 CW (1:4000; Li-COR Biosciences, Lincoln, NE, USA). Then 
the membranes were scanned with an Odyssey Infrared Imaging System (Li-COR Biosciences) for 
analysis  of  the  relative  level  of  apoptosis-related  protein  expression.  The  protein  gray  value  was 
divided by the β-actin gray value. 
3.7. Statistical Analysis 
All data are presented as the mean ±  S.E.M. The statistical significance was examined by ANOVA, 
followed by Dunn's test. Differences were considered significant at p < 0.05. The statistical software 
SPSS 13.0 (SPSS Inc, Chicago, IL) was used for the statistical analyses. 
4. Conclusions 
In  conclusion,  the  results  of  this  study  showed  that  both  ischemic  preconditioning  and 
postconditioning can protect the ischemic brain injury in rats through the same effect on inhibition of 
apoptosis.  Further  study  will  emphasize  how  to  induce  an  optimal  algorithm  of  combination  of  
pre- and post-neuroprotective effects. Int. J. Mol. Sci. 2012, 13  6099 
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